BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7614073)

  • 1. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
    Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
    J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin.
    Newman A; Clutterbuck RD; Powles RL; Millar JL
    Leukemia; 1994 Nov; 8(11):2023-9. PubMed ID: 7967748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM; Yeager AM
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
    Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
    Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
    Straetmans N; Ma DD; Herman P; Zenebergh A; Chang A; Deneys V; De Bruyère M; Ferrant A
    Bone Marrow Transplant; 1995 Mar; 15(3):421-8. PubMed ID: 7599567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
    Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
    Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H; Bruecher J; Claudé R; Hoelzer D
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.
    Dietzfelbinger HF; Lang A; Oberberg D; Rastetter JW; Berdel WE
    Exp Hematol; 1992 Feb; 20(2):178-83. PubMed ID: 1544386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells].
    Hrkal Z; Grebenová D; Cajthamlová H; Soucek J; Bartosová J; Fuchs O; Marinov I; Kobylka P; Klamová H; Sponerová D
    Cas Lek Cesk; 2002 Sep; 141 Suppl():41-6. PubMed ID: 12428422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin.
    Newman A; Clutterbuck RD; Powles RL; Millar JL
    Leukemia; 1994 Feb; 8(2):274-80. PubMed ID: 8309251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.